Pharma/fine chemicals roundup—8 April 2014

06:02 AM | April 8, 2014 | Deepti Ramesh

FDA issues warning letter to GlaxoSmithKline's API plant in Ireland The US FDA issued a warning letter on 18 March to the active pharmaceutical ingredient (API) manufacturing facility of...